Maze Therapeutics Inc.

MAZE | NASDAQ

Price Alert Chart Builder DCF Calculator

$27.69

+$5.30 (+23.67%)

Sep 22, 2026, 2:11 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022
Revenue	n/a	167.5M	n/a	n/a
Cost of Revenue	2.4M	n/a	n/a	n/a
Gross Profit	-2.4M	167.5M	n/a	n/a
Operating Income	-142.9M	57.59M	-98.55M	-111.03M
Interest Income	11.78M	4.65M	1.97M	2.03M
Pretax Income	-131.12M	53.4M	-100.42M	-114.94M
Net Income	-131.12M	52.23M	-100.42M	-114.94M
Selling & General & Admin	34.45M	26.42M	24.61M	22.83M
Research & Development	108.45M	83.5M	73.95M	88.19M
Other Expenses	-2.4M	n/a	n/a	n/a
Operating Expenses	140.5M	109.91M	98.55M	111.03M
Interest Expense	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a
Cost & Expenses	142.9M	109.91M	98.55M	111.03M
Income Tax Expense	n/a	1.17M	n/a	n/a
Shares Outstanding (Basic)	42.98M	43.8M	43.78M	43.78M
Shares Outstanding (Diluted)	42.98M	43.8M	43.78M	43.78M
EPS (Basic)	-3.05	0.08	-2.29	-2.63
EPS (Diluted)	-3.05	0.08	-2.29	-2.63
EBITDA	-128.72M	56.7M	-96.33M	-111.12M
EBIT	-131.12M	53.4M	-100.42M	-114.94M
Depreciation & Amortization	2.4M	3.3M	4.09M	3.82M